• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY S HIV AG/AB COMBO REAGENT KIT; HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 AG, AB (P24) AND SYNTHETIC PEPTIDES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY S HIV AG/AB COMBO REAGENT KIT; HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 AG, AB (P24) AND SYNTHETIC PEPTIDES Back to Search Results
Catalog Number 06P01-60
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/21/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient identifier: multiple = 41413200264 and 11502931192 patient information: no further information was provided.
 
Event Description
The customer obtained false repeat reactive alinity s hiv combo results for 2 samples.The following results were provided: sample id 41413200264: alinity 30.22, 27.13 and 24.56 s/co; wb indeterminate; nat negative sample id 11502931192: alinity 2.31, 2.07 and 2.01 s/co; wb negative/hiv-2 negative; nat negative no impact to patient/donor management was reported.
 
Manufacturer Narrative
Investigation of the customer's issue included a review of the complaint text, complaint activity, trending data device history and field data.Return testing was not completed as returns were not available.Review of complaint activity and trending reports did not identify any issues or trends related to the complaint issue.Device history review for the reagent lot did not identify any non-conformances, potential non-conformances or deviations.Labeling was reviewed and sufficiently addresses the customer's issue.Review of field data for alinity s hiv ag/ab combo, ln, 6p01-60, lot number 12630be00 showed an initial reactive rate of 0.06% and a repeat reactive rate of 0.04%.Assuming a zero prevalence of hiv infections, the specificity for the field data is calculated to be 99.96%, which met the product requirement.Further, the field data are comparable to study data referenced in the alinity s hiv ag/ab combo package insert, where the specificity was 99.92% with a 95% confidence interval of 99.87% to 99.96%.Based on the investigation, no systemic issue or deficiency of the alinity s hiv ag/ab combo, lot 12603be00 was identified.
 
Event Description
The customer obtained false repeat reactive alinity s hiv combo results for 2 samples.The following results were provided: sample id (b)(6): alinity 30.22, 27.13 and 24.56 s/co; wb indeterminate; nat negative sample id (b)(6): alinity 2.31, 2.07 and 2.01 s/co; wb negative/hiv-2 negative; nat negative no impact to patient/donor management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY S HIV AG/AB COMBO REAGENT KIT
Type of Device
HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 AG, AB (P24) AND SYNTHETIC PEPTIDES
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11076702
MDR Text Key223800898
Report Number3002809144-2020-01211
Device Sequence Number1
Product Code QHM
UDI-Device Identifier00380740117184
UDI-Public00380740117184
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 02/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/20/2020
Device Catalogue Number06P01-60
Device Lot Number12630BE00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/02/2020
Initial Date FDA Received12/28/2020
Supplement Dates Manufacturer Received02/05/2021
Supplement Dates FDA Received02/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY S SYSTEM, 06P16-01, AS1217; ALNTY S SYSTEM, 06P16-01, AS1217; ALNTY S SYSTEM, 06P16-01, AS1217
-
-